In the BioHarmony Drug Report Database
Etonogestrel
Implanon, Nexplanon (etonogestrel) is a small molecule pharmaceutical. Etonogestrel was first approved as Implanon on 2006-07-17. Nuvaring’s patents are valid until 2030-07-28 (FDA).
Trade Name
|
Implanon, Nexplanon |
|---|---|
Common Name
|
etonogestrel |
ChEMBL ID
|
CHEMBL1531 |
Indication
|
|
Drug Class
|
Estrogens; progestins |
Image (chem structure or protein)